• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Sep11
Anixa Biosciences released FY2025 9 Months earnings on September 10, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.255
03:00
Anixa Biosciences released FY2025 Q3 earnings on September 10, 2025 (EST), with actual EPS of USD -0.0695 (forecasted EPS USD -0.0866)
03:00
Jul15
Anixa Biosciences CEO Buys Company Stock
08:43
Jun23
Anixa Biosciences Launches Fourth Phase Clinical Trial for Recurrent Ovarian Cancer CAR-T Treatment
12:01
Jun20
Anixa Announces Investor Webcast on June 26
11:52
Jun9
Anixa to Present Ovarian Cancer CAR-T Therapy Clinical Trial Results
12:01

Schedules & Filings

Schedules
Filings
Sep10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.258 M, EPS -0.0695

May28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.79 M, EPS -0.0866

Mar11
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.184 M, EPS -0.0988

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More